Fierce Biotech: Questex's Fierce Biotech Announces the Launch of the Fierce Oncology Newsletter, Provides In-Depth Coverage of the Evolving World of Cancer Therapies

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Questex 's Fierce Biotech , the biotech industry's daily monitor, today announces the launch of the Fierce Oncology newsletter, an exclusive resource for oncology leaders. Delivered bi-weekly, the new newsletter provides in-depth coverage of the evolving world of cancer therapies, offering readers the latest news, analysis, and data on treatments, studies, and key advancements in the oncology space. From drug development and regulatory approvals to clinical trial results and emerging treatment strategies, the Fierce Oncology newsletter will deliver the insights professionals need to navigate this field. The newsletter will offer: Industry-Leading Content: In-depth articles, expert interviews and groundbreaking studies. Professional Insights: Regular contributions from top oncology specialists and researchers. Early Notifications: Upcoming trends and new developments that matter most to oncologists and patients. Rebecca Willumson, Senior Vice President & Publisher, Fierce Life Sciences and Healthcare said, "The newsletter is designed for clinicians, specialists, and industry executives looking for the latest news and trends impacting the industry. The newsletter will provide oncology professionals with valuable knowledge and keep them at the forefront of oncology innovations." The Fierce Oncology newsletter is led by Angus Liu, Deputy Editor, Fierce Pharma. "Oncology remains the largest therapeutic area by sales and programs in development pipelines, with new modalities such as cell therapies, antibody-drug conjugates and multispecific antibodies pushing the boundaries in cancer care," said Liu. "With the launch of Fierce Oncology, our goal is to empower professionals to stay ahead by providing in-depth insights into the oncology field's key movements across talent, R&D, manufacturing, commercialization, business development and fundraising." Sign up for the Fierce Oncology newsletter here . Contact Liu at aliu@questex.com or follow him on X and LinkedIn . Stay connected to Fierce Biotech on X and LinkedIn . About Fierce Biotech Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here . About Questex Questex helps people live better and longer . Questex brings people together in the markets that help people live better : hospitality and wellness; the industries that help people live longer : life science and healthcare; and the technologies that enable and fuel these new experiences . We live in the experience economy - connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here. Media Contact Linda Lam Senior Director of Marketing, Fierce Life Sciences & Healthcare llam@questex.com 20-Year Pro Trader Reveals His "MoneyLine" - Simple Trades A simple line tells you when to buy and when to sell that's helped Nic win 83% of his trades. Click here for access. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.